# Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

> **NCT03408093** · — · COMPLETED · sponsor: **Bayer** · enrollment: 120 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta-1b (Betaseron, BAY86-5046)

## Key facts

- **NCT ID:** NCT03408093
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-03
- **Primary completion:** 2010-03-30
- **Final completion:** 2010-03-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03408093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03408093, "Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03408093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*